In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole
Open Access
- 1 March 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (3) , 501-503
- https://doi.org/10.1128/aac.21.3.501
Abstract
IN vitro susceptibilities of 98 isolates of Brucella melitensis to N-formimidoyl thienamycin, tetracycline, co-trimoxazole, rifampin, and cefoxitin were determined. N-Formimidoyl thienamycin showed good activity which was similar to those of tetracycline and rifampin and different from that of the other beta-lactam antibiotic tested (cefoxitin), which showed poor activity. Co-trimoxazole showed good activity.This publication has 6 references indexed in Scilit:
- MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activitiesAntimicrobial Agents and Chemotherapy, 1980
- Thienamycin: New Beta-Lactam Antibiotic with Potent Broad-Spectrum ActivityAntimicrobial Agents and Chemotherapy, 1979
- In Vitro Activity of ThienamycinAntimicrobial Agents and Chemotherapy, 1978
- Sensitivity of Brucella spp to tetracycline and its analogues.Journal of Clinical Pathology, 1976
- Determination of the In Vitro Sensitivity of Brucella Strains to RifampicinBritish Veterinary Journal, 1976
- In vitro susceptibility of Brucella to various antibiotics.1970